InvestorsHub Logo
Followers 87
Posts 6692
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 40692

Saturday, 10/07/2023 1:13:50 PM

Saturday, October 07, 2023 1:13:50 PM

Post# of 42924
Your referenced article indicates, "On Oct. 3, the Food and Drug Administration (FDA) authorized the updated COVID-19 vaccine by Novavax for people ages 12 and older."

https://www.yahoo.com/lifestyle/novavax-covid-vaccine-224757507.html

However, the mRNA vaccines from Pfizer and Moderna were authorized on Sept 11th. So the Pfizer and Moderna vaccines got first-to-market authorization, and sold 4 million vaccines, before Novavax got out of the starting gate. Again.

https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating

Novavax still shouldn't move to your buy list, according to Motley Fool.

https://www.fool.com/investing/2023/10/07/this-could-be-novavaxs-big-opportunity/

But if the lenz/vaccine/anti-viral cocktail proves successful, that will destroy the Pfizer and Moderna vaccine market, and allow Novavax to gain that market share, in my opinion.